Publications by authors named "B Gust"

Article Synopsis
  • The study investigates the role of the receptor-like protein RLP30 in Arabidopsis thaliana's immunity against the fungal pathogen Sclerotinia sclerotiorum, identifying a small cysteine-rich protein (SCP) as the ligand recognized by RLP30.
  • It highlights that while RLP30 and a related receptor from Nicotiana benthamiana recognize the SCP, they differ in their sequence and the protein forms they respond to, indicating diverse receptor evolution across different plant species.
  • Additionally, RLP30 also interacts with a non-homologous protein from bacteria and enhances resistance in tobacco plants against various pathogens, suggesting its broad role in plant immune responses across different microbial kingdoms.
View Article and Find Full Text PDF

Nine dehydratases involved in the biosynthesis of secondary metabolites in addition to FabZ from fatty acid biosynthesis were investigated for their substrate scope using a panel of -acetylcysteamine (SNAC) thioesters. The best performing enzyme BorDH2 was applied in kinetic resolutions.

View Article and Find Full Text PDF

Background: Caprazamycins are liponucleoside antibiotics showing bioactivity against Gram-positive bacteria including clinically relevant Mycobacterium tuberculosis by targeting the bacterial MraY-translocase. Their chemical structure contains a unique 3-methylglutaryl moiety which they only share with the closely related liposidomycins. Although the biosynthesis of caprazamycin is understood to some extent, the origin of 3-methylglutaryl-CoA for caprazamycin biosynthesis remains elusive.

View Article and Find Full Text PDF

Antibiotic-producing microorganisms usually require one or more self-resistance determinants to survive antibiotic production. The effectors of these mechanisms are proteins that inactivate the antibiotic, facilitate its transport, or modify the target to render it insensitive to the molecule. Streptomyces bacteria biosynthesize various bioactive natural products and possess resistance systems for most metabolites, which are coregulated with antibiotic biosynthesis genes.

View Article and Find Full Text PDF

Brasilicardin A (1) consists of an unusual anti/syn/anti-perhydrophenanthrene skeleton with a carbohydrate side chain and an amino acid moiety. It exhibits potent immunosuppressive activity, yet its mode of action differs from standard drugs that are currently in use. Further pre-clinical evaluation of this promising, biologically active natural product is hampered by restricted access to the ready material, as its synthesis requires both a low-yielding fermentation process using a pathogenic organism and an elaborate, multi-step total synthesis.

View Article and Find Full Text PDF